The colony stimulating factors

Springer Science and Business Media LLC - Tập 10 Số 1-2 - Trang 5-12 - 1993
Mona Hansson1, T Söderström1
1Department of Clinical Immunology and Transfusion Medicine, The Immunhemotherapy Unit, Karolinska Hospital, Stockholm, Sweden

Tóm tắt

Từ khóa


Tài liệu tham khảo

Plutznik D H, Sachs L: The cloning of normal “mast” cells in tissue culture.J Cell Physio1 66, 319 (1965).

Bradley T R, Metcalf D: The growth of mouse bone marrow cellsin vitro.Aust J Exp Biol Med Sci 44, 287 (1966)

Stanley E R, Gullbert L F: Methods of purification, assay, characterization and target cell binding of a colony stimulating factor (CSF-1).Jlmmunol Meth 42, 253 (1981).

Robinson B E, Quesenberry P J: Hematopoietic growth factors.Am J Med Sci 300, 163–170, 237–244, 311–321 (1990).

Metcalf D: The colony stimulating factors; Discovery development and clinical applications.Cancer 65, 2185 (1990).

Gasson J C: Molecular Physiology of Granulocyte-Macrophage Colony stimulating factor (rev).Blood 77(6), 1131 (1991).

Grosh W W, Quesenberry P J: Recombinant Human Hematopoietic Growth factors in the treatment of cytopenias.Clin lmmunol Immunopathol 62(1), 25 (1992).

Moore M A S: Clinical Implications of positive and negative hematopietic Stern Cell Regulators.Blood 78(1), 1 (1991).

Zsebo K M, Wypych J, McNiece I K Lu H S, Smith K A, Karkare S B, Sachdev R K Yuschenkoff V N, Birkett N C, Williams L R, Satyagai V N, Tung W, Bosselman R A, Mendiaz E A, Langley K E: Identification, purification of hematopoieitc stem cell factor from buffalo rat liver-conditioned medium.Cell 63, 195 (1990).

Williams D E, Eisenman J, Baird A, Rauch C, Van Ness K, March C J, Park L S, Martin U, Mochizuki D Y, Boswell H S, Burgess G S, Cosman D, Lyman S D: Identification of a ligand for the c-kit proto-oncogene.Cell 63, 167 (1990).

Haylock D N, To L B, Dowse T L, Juttner C A, Simmons P J: Exvivo Expansion and Maturation of Peripheral Blood CD34+ Cells Into the Myeloid Lineage.Blood 80(6), 1405 (1992).

Lansdorp P M, Dragowska W: Long-Term Erythro-poiesis from Constant Numbers of CD34+ Cells in Serum-free Cultures Initiated with Highly Purified Progenitor Cells from Human Bone Marrow.JExp Med 175, 1501 (1992).

Yokota T, Coffman R L, Hagiwara H, Rennick DM, Takebe Y, Yokoto K Gemmel L, Shrader B, Yang G, Meyerson P, Luh J, Hoy P, Pene J, Briere F, Spits H, Banchereau J, de Vries J, Lee F D, Arai N, Arai K-I: Isolation and characterization of lymphokines cDNA clones encoding mouse and human IgA-enhancing factor and eosinophil colony stimulating factor activities: relationship to IL-5.Proc Natl Acad Sci 84, 7388 (1987).

Moore M A S: The clinical use of Colony Stimulating Factors.Ann Rev Immunol 9, 159 (1991).

Dower S K Smith C A, Parl L S: Human Cytokine receptors.J Clin lmmunot 10(6), 289 (1990).

Olsson I, Gullberg U, LantzM, Richter J: The receptors for regulatory molecules of hematopoiesis.EurJHaemato 148, 1 (1992).

Bazan J F: Structural design and molecular evolution of a cytokine receptor superfamily.Proc Natl Acad Sci USA 87, 6934 (1990).

Sherr C J: Colony stimulating factor-1 receptor.Blood 75, 1 (1990).

Majumder S, ’Brown K, Qiu F-H, Besmer P: e-kit protein, a transmembrane kinase: identification in tissues and characterization.Mol CeUBiol 8, 4896 (1988).

Civin C I, Strauss L C, Brovall C, Fackler M J, Schwartz J F, Shaper J H: Antigenic analysis of hematopoiesis. III. A hematopoietic progenitor cell surface antigen defined by a monoclonal antibody raised against KG-lacells.J lmmunol 133, 157 (1984).

Brandt J E, Baird N, Lu L, Srour E, Hoffman R: Characterization of a human progenitor cell capable of forming blast cell containing coloniesin vitro.J Clin Invest 82, 1017 (1988).

Andrew R G, Singer J W, Bernstein I D: Precursors of colony forming cells in humans can be distinguished from colony forming cells by expression of the CD33 and CD34 antigens and fight scatter properties.J Exp Med 169, 1721 (1989).

Verfaillie C, Blakolmer K, McGlave P: Purified primitive human hematopoietic progenitor cells with long-termin vitro repopulating capacity adhere selectively to irradiated bone marrow stroma.J Exp Med 172, 509 (1990).

Bender J G, Unverzagt K L, Walker D E, Lee W, Van Epps D E, Smith D H, Stewart C C, To L B: Identification and Comparison of CD34-Positive Cells and Their Subpoputations from Normal Peripheral Blood and Bone Marrow Using Multicolor Flow Cytometry.Blood 77(12), 2591 (1991).

Zsebo K M, Williams D A, Geisser EN, Broudy V C, Martin F H, Atkins H L, Hsu R-Y, Birkett N C, Okino K H, Murdock D C, Jacobsen F W, Langley K E, Smith K A, Takeishi T, Cattanach B M, Galli S J, Suggs S V: Stem cell factor is encoded at the S1 locus of the mouse and is the ligand for the c-kit tyrosine kinase receptor.Cell 63, 213 (1990).

Witte O N: Steel locus defines new multipotent growth factor.Cell 63, 5 (1990).

Chabot B, Stephenson D A, Chapman V M, Besmer P, Bernstein A: The proto-onc gene c-kit encoding a transmembrane tyrosine kinase receptor maps to the mouse W locus.Nature 335, 88 (1988).

Le Beau M M, Westbrock C A, Diaz M O, Larson R A, Rowley J D, Gasson J C, Golde D W, Sherr C J: Evidence for the involvement of GM-CSF and FMS in the deletion (5q) in myeloid disorders.Science 231, 984 (1986)

van Leeuwen B H, Martinson M E, Webb G C, Young I G: Molecular organization of the cytokine gene cluster, involving the human IL-3, IL-4, IL-5 and GM-CSF genes on human chromosome 5.Blood 73, 1142 (1989).

Nimer S D, Golde D W: The 5q- abnormality.Blood 70, 1705 (1987).

Le Beau M M, Lemons R S, Espinosa R III, Larson R A, Aral N, Rowley J D: Interleukin-4 and Interleukin-5 map to human chromosome 5 in a region encoding growth factors and receptors and are deleted in myeloid leukemias with a del (5q),Blood 73, 647 (1989).

Thomas J A, Lee D J, Kidd P, Rubin E, Kaufmann J, Bonnem E M, Fefer A: Subcutaneous granulocyte-macrophage colony stimulating factors in patients with myelodysplastic syndrome: Toxicity, pharmacokinetics, and hematological effects.J Clin Oncol 7, 629 (1989).

Vadhan-Raj S, Keating M, LeMaistre A, Hittleman W N, McCreadie K, Trujillo J M, Broxmeyer H E, Henney C, Gutterman J U: Effects of recombinant human granulocytemacrophage colony-stimulating factor in patients with myelodysplastic syndromes.N Engl J Med 317, 1545 (1987).

Hammond W P, Price T H, Souza L M, Dale D C: Treatment of cycfic neutropenia with granulocyte Colony stimulating Factor.N Engl J Med 320, 1306 (1989).

Bonilla M A, Gillio A P, Ruggerio M, Kernan N A, Brochstein J A, Abboud M A, Fumagalli L, Vincent M, Welte K, Souza L M, O’ Reilly R J: Effects of recombinant human granulocyte colony stimulating factor on neutropenia in patients with congenital agranulocytosis.N Engl JMed 320, 1574 (1989).

Siena S, Bregni M, Brando B, Ravagnani F, Bonadonna G, Gianni A M: Circulation of CD34+ hematopoietic stem cells in the peripheral blood of high dose cyclophosphamide treated patients: Enhancement by intravenous recombinant human granulocyte-macrophage colony stimulating factor.Blood 74, 1905 (1989).

Björldaolm M: Aplastic anaemia: pathogenetic mechanisms and treatment with special reference to immunomodulation.J lnt Med 231, 575 (1992).

Hinterberger W, Adolf G, Aichinger G, Dudczak R, Geissler K, Höcker P, Huber C, Kahls P, Knapp W, Köller U, Lechner K, Volc-Ptatzer B: Further evidence for lymphokine overproduction in severe aplastic anemia.Blood 72, 266 (1988).

Antin J H, Smith B R, Holmes W, Rosenthal D S: PhaseI/II study of recombinant human granulocyte-macrophage colony-stimulating factor in aplastic anemia and myelodysplastic syndrome.Blood 72, 705 (1988).

Negrin R S, Heuber D H, Nagler A: Treatment ofmyelodysplastic syndromes with recombinant human granulocyte colony stimulating factor: A Phase I-II trial.Ann lnt Med 110, 979 (1989).

Salmon S, Liu R: Effects of GM-CSF inin vitro growth of human solid tumors.J Clin Oncol 7,1346 (1989).

Bronchud M H, Scarffe J H, Thatcher N: Phase I/lI study of recombinant human G-CSF in patients receiving intensive chemotherapy for small cell lung cancer.Br J Cancer 56, 809 (1987).

Gabrilove J, Jakubowski A, Scher H, Steinberg C, Wong G, Grous J, Yagoda A, Fain K, Moore M, Clarcson B: Effect of granulocyte-macrophage colony stimulating factor on neutropenia and associated morbidity due to chemotherapy for transitional cell carcinoma of the urothelium.N Engl J Med 318, 1414 (1988).

Crawford J, Ozer H, Johnson D, and the G-CSF Study group: Granulocyte colony stimulating factor: Prevention of chemotherapy-induced febrile neutropenia in patients with small cell cancer. A randomized double blind placebo controlled trial.Proc Am Soc Clin Oncol 9, 229 (1990).

Link H, Boogaerts M, Carella A, Ferrant A, Gadner H, Gorin N: Recombinant human granulocyte macrophage colony stimulating factor after autologous bone marrow transplantation for acute lymphoblastic leukemia and non-Hodgkins’s lymphoma: A randomized double blind, multicenter trial in Europe.Blood 76, 152a (1990).

Brugger W, Bross K, Frisch J, Dern P, Weber B, Mertelsmann R, Kanz L: Mobilization of Peripheral Blood Progenitor cells by Sequential Administration of IL-3 and Granulocyte-Macrophage Colony-Stimulating Factor Following Polychemotherapy With Etoposide Ifosfamide and Cisplatin.Blood 79, 1193 (1992).

Kessinger A, Armitage J O: The evolving role of Autologous Peripheral stem cells Transplantation Following High Dose Therapy for Malignancies (Editorial).Blood 77, 211 (1991).

Kessinger A, Axmitage J O, Smith D M, Landmark J D, Bierman P J, Wiesenburger D D: High-dose therapy and autologous peripheral blood stem cell transplantation for patients with lymphoma.Blood 74, 1260 (1989).

Reiffers J, Castaigne S, “lilly H, Lepage E, Leverger G, Henon P, Douay L: Hematopoietic reconsfitution after autologous stem cell transplantation: A report of 46 cases.Plasma Ther Transfis Technol 8, 360 (1987).

Haas R, Ho A D, Bredthauer U, Cayeaux S, Egerer G, Knauf W, Hunstein W: Successful autologous transplantation of blood stem cells mobilized with recombinant human granulocyte-macrophage colony-stimulating factor. ExpHematol 18, 94 (1990).

Gianrti A M, Bregni M, Siena S, Villa S, Sciorelli G A, Ravagnani F, Pellegris G, Bonadonna G: Rapid and complete hemopoietic reconstitution following combine transplantation of autologous blood and bone marrow cells. A changing role for high-dose chemotherapy ?Hematol Oncol 7, 139 (1989).

Dinarello C A: Anti-cytokine strategies.Eur Cytokine Netw 3, 7 (1992).